A systematic literature review informing the consensus statement on efficacy and safety of pharmacological treatment with interleukin-6 pathway inhibition with biological DMARDs in immune-mediated inflammatory diseases

OBJECTIVES: Informing an international task force updating the consensus statement on efficacy and safety of biological disease-modifying antirheumatic drugs (bDMARDs) selectively targeting interleukin-6 (IL-6) pathway in the context of immune-mediated inflammatory diseases. METHODS: A systematic li...

Descripción completa

Detalles Bibliográficos
Autores principales: Kastrati, Kastriot, Aletaha, Daniel, Burmester, Gerd R, Chwala, Eva, Dejaco, Christian, Dougados, Maxime, McInnes, Iain B, Ravelli, Angelo, Sattar, Naveed, Stamm, Tanja A, Takeuchi, Tsutomu, Trauner, Michael, van der Heijde, Desirée, Voshaar, Marieke J H, Winthrop, Kevin, Smolen, Josef S, Kerschbaumer, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Autoimmunity
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462104/
https://www.ncbi.nlm.nih.gov/pubmed/36260501
http://dx.doi.org/10.1136/rmdopen-2022-002359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462104/
https://www.ncbi.nlm.nih.gov/pubmed/36260501
http://dx.doi.org/10.1136/rmdopen-2022-002359

Ejemplares similares